Literature DB >> 17428396

[Prokaryotic expression and purification of RPS13 and preparation of polyclonal antibody against RPS13].

Xue-Yan Guo1, Yong-Quan Shi, Hui-Hong Zhai, Li Sun, Li-Li Liu, Shuang Han, Ting Lei, Dai-Ming Fan.   

Abstract

AIM: To construct prokaryotic expression plasmid of RPS13, express and purify the protein for the preparation of polyclonal antibody.
METHODS: RPS13 gene was amplified by reverse transcription polymerase chain reaction (RT-PCR) from the highly expressed cell of gastric multidrug cell SGC7901/VCR. After sequenced, the gene was cloned into the expression vector pET-28a(+) to construct RPS13 expression plasmid pET-28a(+)-RPS13. The expression plasmid was transformed into the E.coli BL21 and screened by ampiline, and then the E.coli BL21 containing the expression plasmid was induced by IPTG and the protein was purifed by Histag column. BALB/c mice were immunized by the immunogen His-RPS13. The titer was measured by ELISA and the polyclonal antibody was obtained.
RESULTS: The expression plasmid pET-28a(+)-RPS13 was constructed. The 19 kDa recombined protein was successfully expressed in the E.coli BL21 by IPTG for 3 hours, purified by Histag column and confirmed by SDS-PAGE and Western blot. The polyclonal anti-His-RPS13 antibody was obtained by immunizing the mice with RPS13 protein. RPS13 could be specifically recognized by the antibody based on Western blot.
CONCLUSION: RPS13 has bene expressed and purified successfully and polyclonal anti-His-RPS13 antibody has been prepared. Our study can be used for the preparation of monoclonal anti-His-RPS13 antibody and for further research of the function of the RPS13 protein in tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428396

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1).

Authors:  Xueyan Guo; Yongquan Shi; Yawen Gou; Jipeng Li; Shuang Han; Yanqi Zhang; Jianhua Huo; Xiaoxuan Ning; Li Sun; Yu Chen; Shiren Sun; Daiming Fan
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.